FdaApplication
NDA 208083
Identifiers
- fda_app_no: NDA208083
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 2017-04-20 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | CLINDAMYCIN PHOSPHATE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION;INTRAVENOUS |
| CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | CLINDAMYCIN PHOSPHATE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION;INTRAVENOUS |
| CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | CLINDAMYCIN PHOSPHATE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION;INTRAVENOUS |
3 products